Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

PRESS: Glaxo Closes Plant Amid Legionnaire's Disease Fears - NYT

Wed, 12th Aug 2015 08:39

LONDON (Alliance News) - GlaxoSmithKline PLC has shut down a North Carolina plant which produces inhaled medications after it discovered the bacteria which causes Legionnaire's disease at the site, The New York Times reported.

The manufacturing plant in Zebulon was closed on Tuesday after the bacteria was found in cooling towers, the newspaper said. Legionnaire's disease is a deadly form of pneumonia and got its name after an epidemic break-out in 1976 at a Legionnaires' convention held in Philadelphia.

http://www.nytimes.com/2015/08/12/business/glaxosmithkline-plant-closes-after-legionnaires-discovery.html?_r=0

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2015 Alliance News Limited. All Rights Reserved.

Related Shares

More News
28 Jun 2024 19:43

IN BRIEF: GSK reaches settlement over Zantac case in Illinois

GSK PLC - London based pharmaceuticals company - Reaches confidential settlement with Martin Gross resolving the case he filed in Illinois state court...

27 Jun 2024 17:25

European shares subdued ahead of economic data, French elections; H&M plunges

H&M tumbles after missing quarterly profit forecasts *

27 Jun 2024 17:02

London's FTSE 100 slips as investors eye US, UK economic data

FTSE 100 down 0.6%, FTSE 250 adds 0.2% *

27 Jun 2024 16:40

GSK shares slide after US health agency narrows scope of RSV shots

GSK shares fall as much as 7% *

27 Jun 2024 15:48

London close: Stocks mixed ahead of key UK, US data

(Sharecast News) - London stocks ended Thursday's trading session with a mixed performance as market participants awaited crucial US inflation data an...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.